Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Quality Network for Pathology (IQN Path) is a global non-profit umbrella organization dedicated to improving the quality of clinical biomarker testing in pathology. Based in Luxembourg, it brings together external quality assessment (EQA) providers, professional societies, and pharmaceutical industry partners to harmonize standards and promote best practices. The organization facilitates the delivery of proficiency testing and EQA programs, particularly in the fields of molecular pathology and immunohistochemistry. By fostering international collaboration, IQN Path ensures the reliability of diagnostic tests used to inform treatment decisions in oncology and other therapeutic areas. Its work is essential for the successful implementation of personalized medicine on a global scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Quality Network for Pathology.